ABH Healthcare IPO Day 1: Subscription status, review — here's what you need to know
- ABH Healthcare IPO Day 1 total subscription stands at 0.37x.
- QIB category is fully subscribed at 3.45x, leading the issue.
- Retail participation improved to 0.31x, up from 0.09x at open.
- NII (bHNI) jumped 250% to 0.07x during the day.
- Issue closes on 2026-08-27; price band is ₹96.00000 - ₹102.00000.
*this image is generated using AI for illustrative purposes only.
ABH Healthcare’s public issue closed with a total subscription of 1.47x. QIBs led the demand at 8.37x, while Retail investors subscribed 1.65x. The hospital chain’s shares are set to list on September 1, 2026.
Final Subscription Status
The issue saw robust institutional interest, with QIBs accounting for the bulk of the oversubscription. Retail participation crossed the 1x mark by the final day, ticking up significantly in the last hours. NII (bHNI) jumped +145.5% today (from 0.22x to 0.54x), while Retail jumped +47.3% today (from 1.12x to 1.65x).
| Day | Date | QIB | NII (bHNI) | NII (sHNI) | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 | 24-08-2026 | 3.45x | 0.07x | 0.01x | 0.31x | 0.37x |
| Day 2 | 25-08-2026 | 8.37x | 0.13x | 0.18x | 0.62x | 0.88x |
| Day 3 | 26-08-2026 | 8.37x | 0.16x | 0.20x | 0.93x | 1.04x |
| Day 4 | 27-08-2026 | 8.37x | 0.54x | 0.32x | 1.65x | 1.47x |
Intra-day timeline on 27-08-2026
| Time (IST) | QIB | NII (bHNI) | Retail | Total |
|---|---|---|---|---|
| 11:15 | 8.37x | 0.22x | 1.12x | 1.14x |
| 12:15 | 8.37x | 0.30x | 1.23x | 1.20x |
| 13:15 | 8.37x | 0.37x | 1.35x | 1.28x |
| 14:15 | 8.37x | 0.42x | 1.46x | 1.36x |
| 15:15 | 8.37x | 0.49x | 1.54x | 1.41x |
| 16:15 | 8.37x | 0.54x | 1.65x | 1.47x |
Category-wise Breakdown
- QIB: 8.37x (Leading category)
- NII (bHNI): 0.54x
- NII (sHNI): 0.32x
- Retail: 1.65x
- Employees: 0x
About the Company
ABH Healthcare Limited operates a 150-bed multi-specialty tertiary care hospital under the "Anil Baghi Hospital" brand in Ferozepur, Punjab. Founded in 2021, the company acquired the business of M/s. Anil Baghi Hospital in 2022. It offers services across 25 medical specialties, including cardiac sciences and neurology, led by U.S.-trained doctors.
Financial Highlights
The company has shown consistent growth in revenue and profit over the last three fiscal years.
| Metric (₹ crores) | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|
| Revenue from Operations | 41.38 | 49.27 | 52.51 |
| Total Profit (PAT) | 1.66 | 5.35 | 5.64 |
| Total Equity | 6.35 | 11.69 | 17.34 |
Revenue grew from ₹41.38 crores in FY 2024 to ₹52.51 crores in FY 2026. Profit after tax increased significantly from ₹1.66 crores to ₹5.64 crores in the same period.
Objects of the Issue
- Repayment/prepayment of certain borrowings: ₹17.00 crores
- Funding working capital requirements: ₹5.00 crores
- Funding inorganic growth through unidentified acquisitions and general corporate purposes
Risk Factors
- Limited operating history as a company since incorporation in March 2021.
- Geographic revenue concentration risk with 100% revenue from its Ferozepur location.
- High debt-to-equity ratio of 3.20 in Fiscal 2026.
What's Next
Allotment is expected on August 28, 2026. The shares will list on NSE and BSE on September 1, 2026. The basis of allotment will be determined by the Registrar to the Issue.
Will the strong QIB subscription of 3.45x be sufficient to offset the weak retail and HNI participation, or will the IPO likely face an oversubscription shortfall by the closing date?
How might the company's plan to use IPO proceeds for 'unidentified acquisitions' impact its valuation stability given its current high debt-to-equity ratio of 3.20?
What is the potential upside for ABH Healthcare's stock price post-listing if the broader healthcare sector in Tier 3 cities continues to attract institutional capital?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
